News Center
Min Wang
2024-01-29
Wang Min is currently responsible for analytical method development and quality control at Immorna. He previously worked at Hongyun Huaning (Hangzhou) Biopharmaceutical Co., Ltd., gaining 10 years of experience in the development of analytical methods and quality control for biopharmaceuticals. As a key team member, he participated in the GLP-1 long-acting drug, antibody drug, and several non-self-replicating mRNA and self-replicating srRNA projects, contributing to clinical submissions and pharmaceutical research of clinical trials in China.
SAF Coolest v1.3.1.1 设置面板 AOOSX-AWNY-HASAE-ZAD
图片ALT信息： Hangzhou Immorna Biotech Inc.
违禁词： First, best, first-class, leading, unique, king, leader, leader, extreme,
无数据提示
Sorry, the current column is being updated, please look forward to it!
You can view other columns or returnHome Page